← Reviews
Open accessFull analysisJun 16, 2026

Fiber and polyphenol-rich dietary interventions: gut microbiome-mediated health effects

This narrative review synthesizes evidence that fiber- and polyphenol-rich diets favorably modulate gut microbial composition and SCFA production, but provides no pooled quantitative estimates or formal meta-analysis to support magnitude of effect claims.

The question (PICO)
PopulationGeneral adult humans, including subgroups with cardiometabolic risk, aging, and chronic diseases
InterventionFiber- and/or polyphenol-rich diets (spices, legumes, nuts, fruit, cocoa, whole grains, Mediterranean and Green-Mediterranean dietary patterns)
ComparatorTypical Western diet or habitual baseline (not standardized across cited studies)
OutcomeGut microbial composition and diversity, SCFA production (acetate, propionate, butyrate), inflammatory markers (IL-6, IFN-γ, IL-17, NF-κB), gut barrier integrity, cardiometabolic risk factors
CEvidence
Study
Review
Effect
Favorable

Context

Poor dietary habits — excess sodium, meat, sugar, and trans fats — are established risk factors for non-communicable diseases. The gut microbiome mediates part of this risk by converting dietary substrates into immunometabolic effectors. Microbiome-targeted dietary interventions represent a potentially modifiable public health strategy.

What the study showed

The review describes mechanisms by which fermentable fibers and polyphenols increase butyrate producers (Faecalibacterium, Roseburia, Ruminococcus) and propionate producers (Akkermansia, Bacteroides), with downstream reductions in pro-inflammatory cytokines (IL-6, IFN-γ, IL-17) and strengthened tight junctions. Branched-chain fatty acids (BCFAs), markers of excessive protein fermentation, decrease when transitioning from a Western to a Mediterranean diet. No pooled data with 95% CIs or effect sizes are reported; figures cited originate from heterogeneous primary studies not subject to meta-analysis.

How it was done

Narrative review published in 2025 in Frontiers in Nutrition; no PRISMA protocol, explicit inclusion/exclusion criteria, systematic search strategy, or formal risk-of-bias assessment. Synthesizes mechanistic microbiology, in vitro studies, animal studies, and clinical trials of unstandardized size and quality.

Effect magnitude

Not applicable: no pooled effect size (OR, RR, SMD, MD) with 95% CI is calculated; the review is narrative and mechanistic, without quantitative synthesis.

Limitations

No systematic protocol (no PRISMA/AMSTAR-2 compliance), no risk-of-bias assessment of included studies (RoB 2 or ROBINS-I not applied), unquantified heterogeneity across populations and interventions, uncontrolled literature selection bias, and unstratified mixing of in vitro, animal, and human evidence. The review does not support direct causal inference for clinical practice.

In clinical practice

Clinicians may advise increased fermentable fiber and polyphenol-rich food intake as part of a healthy dietary pattern, based on mechanistic plausibility and consistent primary evidence — but must not quantify expected benefits from this review alone. Individualized clinical decisions require consulting outcome-specific meta-analyses and RCTs.

What is still missing

Adequately powered RCTs and outcome-specific meta-analyses targeting hard clinical endpoints (mortality, cardiovascular events, diabetes progression) with standardized fiber/polyphenol doses and functional microbiome measures are needed.

Microbiota Weekly

The week in microbiota evidence, in your language. Structured summaries, traceable to the source.